Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
03/21/1996 | WO1996008228A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
03/21/1996 | CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
03/21/1996 | CA2199484A1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
03/20/1996 | EP0702013A2 Imidazopyridines |
03/20/1996 | EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists |
03/20/1996 | EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent |
03/20/1996 | EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
03/20/1996 | CN1119014A Benzopyranes as potassium channel openers |
03/20/1996 | CN1119013A Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
03/20/1996 | CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines |
03/20/1996 | CN1031339C Process for preparation of heterocyclically substituted phenylacetic acid derivatives |
03/19/1996 | US5500429 Cardiovascular |
03/19/1996 | US5500222 Mixed with monoglyceride permeation enhancer |
03/16/1996 | CA2158225A1 Imidazopyridines |
03/14/1996 | WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
03/14/1996 | WO1996007653A1 Endothelin receptor antagonists |
03/14/1996 | WO1996007426A1 Enteral vaccine for vaginal infections |
03/14/1996 | CA2199255A1 Enteral vaccine for vaginal infections |
03/13/1996 | EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation |
03/13/1996 | EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them |
03/13/1996 | EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands |
03/13/1996 | EP0700293A1 Dihydrotestosterone for use in androgenotherapy |
03/13/1996 | EP0700284A1 Controlled release oxybutynin formulations |
03/13/1996 | CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same |
03/13/1996 | CA2157998A1 Pharmaceutical compounds |
03/12/1996 | US5498722 Hypotensives |
03/12/1996 | US5498598 Composition for nasal administration of desmopressin |
03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
03/07/1996 | WO1996006845A1 Substituted 9-alkyladenines |
03/07/1996 | WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
03/07/1996 | WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives |
03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
03/07/1996 | CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
03/06/1996 | EP0699204A1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
03/06/1996 | EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
03/06/1996 | EP0699185A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
03/06/1996 | EP0699069A1 Endothelin receptor antagonists |
03/06/1996 | CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
03/05/1996 | US5496823 Administering propentofylline or a salt thereof to a patient |
03/05/1996 | US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it |
03/05/1996 | US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative |
02/29/1996 | WO1996005837A1 Use of n-substituted phenothiazines |
02/29/1996 | WO1996005835A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
02/29/1996 | WO1996005833A1 Methods of inhibiting endometrial cancer |
02/29/1996 | WO1996005832A1 Methods of inhibiting primary endometrial hyperplasia |
02/29/1996 | DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines |
02/29/1996 | CA2198256A1 Use of n-substituted phenothiazines |
02/29/1996 | CA2198120A1 Methods of inhibiting primary endometrial hyperplasia |
02/29/1996 | CA2198119A1 Methods of inhibiting endometrial cancer |
02/29/1996 | CA2198090A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
02/28/1996 | EP0698614A1 Endothelin-antagonizing peptide |
02/28/1996 | EP0698094A1 Bmp-11 compositions |
02/28/1996 | EP0698040A1 Lhrh antagonists |
02/28/1996 | EP0698020A1 Pyrimidine derivatives |
02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
02/28/1996 | CN1117484A Fatty acid derivatives |
02/27/1996 | US5495021 Benzo[f]quinolinones |
02/27/1996 | US5494670 Method of treating ketosis |
02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
02/22/1996 | WO1996005221A1 Calcitonin receptor |
02/22/1996 | WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
02/22/1996 | WO1996004930A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
02/22/1996 | WO1996004905A1 Phenoxyphenylacetic acid derivatives |
02/22/1996 | CA2195758A1 Phenoxyphenylacetic acid derivatives |
02/21/1996 | EP0697410A1 54-substituted alkylidene 2-(N-cyanoimino)-thiazolidin-4-one derivatives, their preparation and their use as aldose reductase inhibitors |
02/21/1996 | EP0696919A1 Diagnosis and treatment of erectile dysfunction |
02/21/1996 | EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers |
02/21/1996 | CN1117045A Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
02/21/1996 | CN1117044A Substituted N-heteroaroaroylguanidin, preparation, pharmaceutical application and medicine containg same |
02/21/1996 | CN1116937A Chinese herb medicine preparation for treating prostate hyperplasia and its preparing method |
02/21/1996 | CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents |
02/20/1996 | US5492923 Drug for treating arterial hypertension and atherosclerosis |
02/20/1996 | US5492921 Preventing restenosis |
02/20/1996 | US5492713 Nutriment preparation |
02/15/1996 | WO1996004276A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
02/15/1996 | WO1996004275A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
02/15/1996 | WO1996004241A2 Benzoylguanidine derivatives as medicaments |
02/15/1996 | WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
02/15/1996 | CA2196763A1 Benzoylguanidine derivatives as medicaments |
02/15/1996 | CA2196219A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
02/15/1996 | CA2196218A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
02/14/1996 | EP0696455A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
02/14/1996 | CN1116524A Formes galeniques a liberation prolongee du chlorhydrate d'alfuzosine |
02/13/1996 | US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
02/13/1996 | US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma |
02/13/1996 | US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
02/08/1996 | WO1996003143A1 Methods for treating bleeding disorders |
02/08/1996 | WO1996003140A1 HLA binding peptides and their uses |
02/08/1996 | WO1996003138A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
02/08/1996 | WO1996003130A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
02/07/1996 | EP0695309A1 Oxytocin antagonist |